Related Experiment Video
Updated: Aug 20, 2026

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
Published on: January 6, 2014
Cancer vaccines
1Cancéropôle Lyon Rhône-Alpes, France. jybonnefoy@canceropole-lyonrhonealpes.com
Abstract:
Cancer vaccines - a dream or a reality? There is no doubt that a time will come when this new approach to cancer treatment will provide opportunities that will be both complementary and synergistic with existing treatments. Novelty is often linked to risk, and if there is a given medical field that desperately needs therapeutic improvement, cancer is it. Recent advances on the understanding of the functioning and manipulation of the immune system and on the host-tumour relationship, and on tumour escape, will soon pay off. However, the development of cancer vaccines is not an easy undertaking and the multitude of obstacles are presented and reviewed in this article. The cancer vaccine 'detractors' that are arguing negatively on the chances of success are, to this date, correct. Nevertheless, a parallel could be drawn from the monoclonal antibodies, which have suffered from a long and difficult history, to hold promise in man. Recent technological progress has once again demonstrated that one can eventually bypass the commonly accepted barriers, as there are now monoclonal-based products currently helping patients. The entire oncology community is eagerly awaiting the next chapter in the cancer vaccine story.
Insights
Cancer vaccines represent a promising frontier in oncology, offering potential synergistic benefits with current treatments. Despite significant hurdles, ongoing research in immunology and tumor biology fuels optimism for future therapeutic advancements.
Area of Science:
- Immunology
- Oncology
- Cancer Therapeutics
Background:
- Cancer treatment urgently requires novel therapeutic strategies.
- Recent progress in understanding the immune system, host-tumor interactions, and tumor immune evasion mechanisms is paving the way for new treatments.
- Cancer vaccines are being explored as a complementary and synergistic approach to existing therapies.
Purpose of the Study:
- To review the challenges and obstacles in the development of cancer vaccines.
- To assess the current reality and future prospects of cancer vaccines in clinical practice.
Main Methods:
- Review of current scientific literature and technological advancements in cancer vaccine development.
- Analysis of historical parallels with other therapeutic modalities, such as monoclonal antibodies.
- Discussion of the immunological and biological factors influencing cancer vaccine efficacy.
Main Results:
- The development of effective cancer vaccines faces numerous significant obstacles.
- Despite challenges, recent technological progress suggests that conventional barriers may be overcome.
- Parallels with the development of monoclonal antibodies indicate that even difficult therapeutic avenues can eventually yield successful treatments.
Conclusions:
- Cancer vaccines hold significant promise as a future cancer treatment modality.
- Continued research and technological innovation are crucial for realizing the potential of cancer vaccines.
- The oncology community anticipates further developments in cancer vaccine technology and application.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Prevention
Some...
Cancer Prevention
Some...

